Cover Image
市場調查報告書

頭頸椎癌症診斷的全球市場:2015年∼2019年

Global Head and Neck Cancer Diagnostics Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 342624
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
頭頸椎癌症診斷的全球市場:2015年∼2019年 Global Head and Neck Cancer Diagnostics Market 2015-2019
出版日期: 2015年10月21日 內容資訊: 英文 71 Pages
簡介

全球頭頸椎癌症診斷市場,預計從2014年到2019年的年複合成長率為12.86%。

本報告提供全球頭頸椎癌症診斷市場相關調查分析、市場規模與成長率、市場趨勢、市場的推動要素與課題、市場機會驗證、主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要的產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

第5章 頭頸椎癌症:概要

  • 關於疾病
  • 分子診斷

第6章 醫療費償付、保險範圍:概要

  • 現狀
  • 美國的醫療費償付結構
  • EU的醫療費償付結構
  • 醫療費償付政策的一般問題

第7章 市場環境

  • 市場概要
  • 市場規模、預測
  • 波特的五力分析

第8章 市場區隔:各手法

  • 影像診斷
  • 內視鏡
  • 牙科診斷
  • 切片檢查

第9章 地區區分

  • 南北美洲的的頭頸椎癌症診斷市場
  • EMEA (歐洲、中東、非洲) 的頭頸椎癌症診斷市場
  • APAC的頭頸椎癌症診斷市場

第10章 市場成長的促進要素

  • 影像診斷的需求
  • 對早期疾病診斷的關注
  • 新興各國的成長可能性

第11章 促進要素的影響

第12章 市場課題

  • 整體費用高
  • 醫療費償付的問題
  • 先進各國的市場飽和

第13章 促進要素、課題的影響

第14章 市場趨勢

  • 技術進步
  • 多重模式影像系統的利用
  • 癌症診斷的生物標記

第15章 業者情勢

  • 競爭情形
  • 市場佔有率分析
  • 其他有潛力的供應商

第16章 主要供應商分析

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Varian Medical Systems

第17章 附錄

第18章 關於Technavio

圖表清單

目錄
Product Code: IRTNTR7458

About head and neck cancer

Various types of malignant tumors grown in and around head and neck are collectively known as head and neck cancers. Most head and neck cancers usually begin in the squamous cells that line the moist mucosal surfaces inside the mouth, throat, and nose. This is often identified as squamous cell carcinoma. The cancers start in the oral cavity, nasal cavity, larynx, salivary glands, pharynx, and paranasal sinuses. Also, other types of cancer may arise near the brain, thyroid, esophagus, and eye. Some of the diagnostic methods used to diagnose head and neck cancers are diagnostic imaging, endoscopy, biopsy, and dental diagnostics.

Technavio's analysts forecast the global head and neck cancer diagnostics market to grow at a CAGR of 12.86% over the period 2014-2019.

Covered in this report

In this report, Technavio covers the present scenario and growth prospects of the global head and neck cancer diagnostics market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of various equipment used for the following diagnostic methods:

  • Diagnostic imaging
  • Endoscopy
  • Biopsy
  • Dental diagnostics

Technavio's report, Global Head and Neck Cancer Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top-four vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Varian Medical Systems

Other Prominent Vendors

  • Accuray
  • Aribex
  • ASAHI Roentgen
  • BrainLab
  • Bruker
  • Carestream
  • Elekta
  • Esaote
  • Fujifilm Holdings
  • Hitachi Medical
  • Hologic
  • Identafi
  • Karl Storz
  • LED Medical Diagnostics
  • Mediso
  • MinXray
  • Neurologica
  • NeuSoft
  • Shimadzu
  • Toshiba
  • Xoran

Market driver

  • Increase in demand for diagnostic imaging
  • For a full, detailed list, view our report

Market challenge

  • High cost
  • For a full, detailed list, view our report

Market trend

  • Advances in technology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Head and neck cancer: An overview

  • About the disease
  • Molecular diagnostics

PART 06: Reimbursement and coverage: An overview

  • Current scenario: Validating diagnostic tests
  • Reimbursement structure in the US
  • Reimbursement structure in EU
  • Prevailing issues of reimbursement policies

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by method

  • Diagnostic imaging
  • Endoscopy
  • Dental diagnostics
  • Biopsy

PART 09: Geographical segmentation

  • Head and neck cancer diagnostics market in Americas
  • Head and neck cancer diagnostics market in EMEA
  • Head and neck cancer diagnostics market in APAC

PART 10: Market drivers

  • Demand for diagnostic imaging
  • Focus on early disease diagnosis
  • Growth potential of emerging countries

PART 11: Impact of drivers

PART 12: Market challenges

  • High overall expenses
  • Reimbursement issues
  • Market saturation in developed countries

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Advances in technology
  • Use of multi-modality imaging systems
  • Biomarkers for cancer diagnosis

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Varian Medical Systems

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Risk factors for head and neck cancers
  • Exhibit 03: Reimbursement perspectives of healthcare entities
  • Exhibit 04: Global head and neck cancer diagnostics market 2014-2019 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global head and neck cancer diagnostics market segmentation by method
  • Exhibit 07: Global head and neck cancer diagnostics market segmentation by method 2014
  • Exhibit 08: Global head and neck cancer diagnostics market segmentation by geography 2014
  • Exhibit 09: Head and neck cancer diagnostics market in Americas 2014-2019 ($ billions)
  • Exhibit 10: Head and neck cancer diagnostics market in EMEA 2014-2019 ($ billions)
  • Exhibit 11: Head and neck cancer diagnostics market in APAC 2014-2019 ($ billions)
  • Exhibit 12: Global head and neck cancer diagnostics market by geography 2014-2019 ($ billions)
  • Exhibit 13: Global head and neck cancer diagnostics market by geography 2014-2019
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: GE Healthcare: Key takeaways
  • Exhibit 17: Philips Healthcare: Key takeaways
  • Exhibit 18: Siemens Healthcare: Key takeaways
  • Exhibit 19: Varian Medical Systems: Key takeaways
  • Exhibit 20: Philips Healthcare: Business segmentation by revenue 2014
  • Exhibit 21: Geographical segmentation by revenue 2014
  • Exhibit 22: Siemens Healthcare: Business segmentation
  • Exhibit 23: Siemens Healthcare: Geographical segmentation by revenue 2014
  • Exhibit 24: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 25: Geographical segmentation by revenue 2014
Back to Top